Vitura Health Ltd - Asset Resilience Ratio

Latest as of June 2024: 16.76%

Vitura Health Ltd (VIT) has an Asset Resilience Ratio of 16.76% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Vitura Health Ltd (VIT) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$11.94 Million

≈ $8.45 Million USD Cash + Short-term Investments

Total Assets

AU$71.28 Million

≈ $50.44 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2024–2024)

This chart shows how Vitura Health Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Vitura Health Ltd.

Liquid Assets Composition Over Time

This chart breaks down Vitura Health Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Vitura Health Ltd (VIT) long-term investment share to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$11.94 Million	16.76%
Total Liquid Assets	AU$11.94 Million	16.76%

Asset Resilience Insights

Good Liquidity Position: Vitura Health Ltd maintains a healthy 16.76% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Vitura Health Ltd Industry Peers by Asset Resilience Ratio

Compare Vitura Health Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Harbin Gloria Pharmaceuticals SHE:002437	Drug Manufacturers - Specialty & Generic	9.04%
Jiuzhitang Co Ltd SHE:000989	Drug Manufacturers - Specialty & Generic	7.86%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%

Annual Asset Resilience Ratio for Vitura Health Ltd (2024–2024)

The table below shows the annual Asset Resilience Ratio data for Vitura Health Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-06-30	16.76%	AU$11.94 Million ≈ $8.45 Million	AU$71.28 Million ≈ $50.44 Million	--

pp = percentage points

About Vitura Health Ltd

AU:VIT Australia Drug Manufacturers - Specialty & Generic

Market Cap

$8.91 Million

AU$12.59 Million AUD

Market Cap Rank

#27460 Global

#1341 in Australia

Share Price

AU$0.02

Change (1 day)

+0.00%

52-Week Range

AU$0.02 - AU$0.07

All Time High

AU$0.96